FutureWorld (FWDG) CB Scientific to Present "Best New Product" Hopeful..."Personal Analytics"

ST. PETERSBURG, FL, Sept. 2, 2014 (GLOBE NEWSWIRE) -- FutureWorld Corp (FWDG), the leading provider of advanced solutions to the Cannabis industry globally, is pleased to announce that its research team at CB Scientific, a wholly owned subsidiary of FWDG, is set to launch "Personal Analytics" - the first ever Cannabinoid Detection Kits designed specifically for use by individual consumers. Over a year in development, "Personal Analytics" is now in production and set to debut at The HIGH TIMES Cannabis Cup in Everett, WA this weekend (Sept. 6th and 7th, 2014). "The real "Feather in the Cap" would be to win best product at the Cup, but regardless of whether or not this happens, we feel fairly certain that timing and need will drive this product around the globe", said FutureWorld Corp. VP, Cameron Cox.

"Personal Analytics" will offer the "first ever affordable cannabinoid detection and relative potency kits" available for THC and CBD, which can be used by individual consumers in this fast paced and growing global Cannabis industry. CB Scientific has priced and packaged "Personal Analytics" for retail consumers and growers alike: these new products are set to break down the walls of mystery among consumers, retailers and producers for far too long. "This new invention is way overdue, and something we have been working toward for years." says Charlie Steinberg, the head of CB Scientifics' research and development program and co-owner of Herbal Synergy LLC.

"There is no greater tragedy in the cannabis markets worldwide than seeing patients suffer for lack of proper identification of cannabinoids in the products they are relying upon, so heavily, to help heal and reduce suffering" says Bill Short, COO of CB Scientific.

As CB Scientific is set to launch "Personal Analytics" - the first ever Cannabinoid Detection Kits, designed for use by individual consumers; FutureWorld will continue to design and refine highly sensitive analytics products in the coming months and strive to set new standards in cannabis production and consumption.

CB Scientific is also proud to be an official sponsor of The HIGH TIMES Cannabis Cup in Everett (Seattle) WA this September 6th and 7th. If you don't have any plans, come on out and join us while we unveil Personal Analytics to the world!


FutureWorld (Other OTCQB: FWDG), a Delaware corporation, is a U.S. Diversified Holding Company, listed on the Over the Counter exchange, which was formed to capitalize on the burgeoning Cannabis markets globally. FutureWorld, together with its subsidiaries, focuses on the identification, acquisition, development, and commercialization of cannabis related products, such as industrial Hemp. HempTech, a subsidiary of FutureWorld, is a technology division catered to the cannabis and the industrial Hemp market. HempTech provides smart sensor technology, communication network, surveillance security, data analysis for smart cultivation and consultation for the industrial hemp and legal medicinal marijuana. Our wireless agricultural smart sensor networks offer precision to the agriculture, irrigation systems, and greenhouses for the global Hemp industry. FutureWorld and its subsidiaries do not grow, distribute or sell marijuana. To request further information about FutureWorld, please email us at investors@futureworldcorp.com, log onto our website athttp://www.futureworldcorp.com/ or visit us at our Facebook pagehttps://www.facebook.com/futureworldcorp.


CB Scientific (http://www.cbscientific.com) is a wholly owned Nevada company based in Denver Colorado. CB Scientific has a working relationship with Herbal Synergy LLC in Colorado and is continuing to develop new technologies specifically for cannabis analytics. Senior management team includes Charlie Steinberg and Derek Lebahn. Mr. Steinburg and Mr. Lebahn of Herbal Synergy and CB Scientific are some of the primary men advancing gas chromatography testing in Colorado. Herbal Synergy LLC has pioneered residual solvent testing for medical cannabis and has always strived to help patients know exactly what they are buying. CB Scientific believes every product sold to patients as "Medical Quality" should be inspected for health benefits, safety, consistency, purity, potency and packaged properly for distribution.

Senior management team of CB Scientific have worked with many of the cannabis industry leaders in Colorado and have also been featured in cannabis industry publications including High Times Magazine, many trade publications, on-air interviews and panel discussions across the United States.

CB Scientific's focus has been the education and safety of consumers combined with innovation to put power into the hands of the patients. Values that FutureWorld is pleased to embrace while ever striving to raise the bar of cannabis analytics even higher.

Safe Harbor

This release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 27E of the Securities Act of 1934. Statements contained in this release that are not historical facts may be deemed to be forward-looking statements. Investors are cautioned that forward-looking statements are inherently uncertain. Actual performance and results may differ materially from that projected or suggested herein due to certain risks and uncertainties including, without limitation, ability to obtain financing and regulatory and shareholder approval for anticipated actions.

CONTACT: FutureWorld Corp. Investor Relations info@futureworldcorp.com cox@futureworldcorp.com (727) 474-1816 ext. 103

Source:FutureWorld Energy Inc.